Daihan Pharmaceutical Co.Ltd (023910) — Free Cash Flow Generation Index
Daihan Pharmaceutical Co.Ltd (023910) has a Free Cash Flow Generation Index of -0.14x as of September 2025. Free cash flow of ₩-1.32 Billion represents 0% of operating cash flow (₩9.47 Billion). Read Daihan Pharmaceutical Co.Ltd (023910) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Daihan Pharmaceutical Co.Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Daihan Pharmaceutical Co.Ltd across 11 annual periods. Explore 023910 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Daihan Pharmaceutical Co.Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Daihan Pharmaceutical Co.Ltd. For the full company profile including market capitalisation, see Daihan Pharmaceutical Co.Ltd market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.56x | ₩19.84 Billion | ₩35.64 Billion | ₩15.80 Billion | ▲ +23.1% |
| 2023 | 0.45x | ₩17.58 Billion | ₩38.86 Billion | ₩21.28 Billion | ▼ -35.6% |
| 2022 | 0.70x | ₩20.38 Billion | ₩29.00 Billion | ₩8.62 Billion | ▼ -0.8% |
| 2021 | 0.71x | ₩28.77 Billion | ₩40.62 Billion | ₩11.85 Billion | ▼ -15.7% |
| 2020 | 0.84x | ₩28.27 Billion | ₩33.63 Billion | ₩5.36 Billion | ▼ -43.6% |
| 2019 | 1.49x | ₩52.57 Billion | ₩35.26 Billion | ₩17.30 Billion | ▼ -26.9% |
| 2018 | 2.04x | ₩91.63 Billion | ₩44.94 Billion | ₩46.69 Billion | ▲ +0.5% |
| 2017 | 2.03x | ₩41.50 Billion | ₩20.45 Billion | ₩21.05 Billion | ▲ +13.7% |
| 2016 | 1.78x | ₩49.82 Billion | ₩27.92 Billion | ₩21.90 Billion | ▲ +46.2% |
| 2015 | 1.22x | ₩21.94 Billion | ₩17.98 Billion | ₩3.96 Billion | ▼ -42.0% |
| 2014 | 2.10x | ₩19.95 Billion | ₩9.48 Billion | ₩10.47 Billion | — |